Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.
Indian J Cancer
;
1996 Mar; 33(1): 17-20
Artigo
em Inglês
| IMSEAR
| ID: sea-50995
ABSTRACT
Ondansetron was used as an antiemetic along with dexamethasone during 16 cycles of highly or moderately ematogenic chemotherapy. There was major control in two cycles and complete control in the remaining 14. Side effects were minor and did not require discontinuation of the drug. This combination, therefore, appears to be safe and effective in preventing chemotherapy induced emesis.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Antagonistas da Serotonina
/
Vômito
/
Feminino
/
Humanos
/
Masculino
/
Dexametasona
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Receptores de Serotonina
/
Ondansetron
/
Adulto
Idioma:
Inglês
Revista:
Indian J Cancer
Ano de publicação:
1996
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS